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A B S T R A C T
While contributions of microglia and astrocytes are regularly studied in various injury models, how these con-
tributions differ across development remains less clear. We previously demonstrated developmental differences in
microglial profiles across development in an injury model of the gustatory system. Nerves of the rat gustatory
system have limited capacity to regenerate if injured during neonatal ages but show robust recovery if the injury
occurs in adulthood. Using this developmentally disparate model of regenerative capacity, we quantified
microglia and astrocytes in the rostral nucleus of the solitary tract (rNTS) following transection of the gustatory
chorda tympani nerve (CTX) of neonatal and adult rats. We found that neonatal CTX induced an attenuated
microglia response but a larger astrocyte response compared to adult CTX. To elucidate the interplay between the
microglia and astrocyte responses in the CTX model, we used our novel intraperitoneal injection protocol for the
colony-stimulating factor 1 receptor inhibitor PLX5622 to deplete microglia in the neonatal and adult rat brain
prior to and after CTX. PLX5622 depleted microglia by 80–90% within 3 days of treatment, which increased to >
90% by 7 days. After 14 days of PLX5622 treatment, microglia were depleted by > 96% in both neonates and
adults while preserving baseline astrocyte quantity. Microglia depletion eliminated the adult astrocyte response to
CTX, while the neonatal astrocyte response after injury remained robust. Our results show injecting PLX5622 is a
viable means to deplete microglia in neonatal and adult rats and suggest developmentally distinct mechanisms for
astrogliosis following neural injury.
1. Introduction
The profound malleability of the developing nervous system can be
both facilitating (Himes and Tessler, 1989; Villablanca et al., 1986) and
detrimental (Kolb et al., 1987; Omelian et al., 2016; Sollars, 2005; Taylor
and Alden, 1997) to injury recovery. Such plasticity is facilitated in part
by microglia and astrocytes, omnipresent co-functioning innate immune
glial cells of the central nervous system.Microglia and astrocytes increase
in number, assume a reactive morphology, as well as upregulate and
secrete pro and anti-inflammatory cytokines following central nervous
system injury (Bylicky et al., 2018; Gao et al., 2013; Sofroniew, 2014),
inflammation induction (Liddelow et al., 2017; Smith et al., 2014), and
disease (Heneka et al., 2015; Stephenson et al., 2018). Comparable re-
sponses are induced in the central terminals or around the centrally
located cell bodies of axotomized peripheral nerves such as the sciatic
nerve (Hu et al., 2007), infraorbital nerve (Melzer et al., 2001), facial
motor neurons (Graeber et al., 1998; Tyzack et al., 2014). Differences in
the magnitude, function, and inflammatory profiles of microglia and
astrocytes following injury are associated with differences in primary and
secondary damage (Cherry et al., 2014; Tang and Le, 2016) and recovery
outcomes (Liddelow et al., 2017; Pekny and Pekna, 2014) and appear to
vary based on developmental stage (Goranova et al., 2009; Melzer et al.,
2001).
A useful model with which to study the interaction between devel-
opmental differences in glia responses and injury recovery is that of the
chorda tympani transection (CTX). The chorda tympani (CT) innervates
fungiform and a small subset of foliate taste buds on the tongue, trans-
mitting gustatory information to the rostral nucleus of the solitary tract
(rNTS) of the brainstem. Fifty days after neonatal ( 10 days of age; 
P10) CTX fungiform taste buds and CT fibers in the rNTS are almost
completely absent (Martin et al., 2019; Sollars, 2005). This lack of re-
covery is associated with a subdued yet significant microglia response in
the central CT fibers in the rNTS (Riquier and Sollars, 2017). CTX in
adulthood (> P40), in contrast, has no such long-term effects as recovery
is nearly complete (Kopka et al., 2000; Reddaway et al., 2012; St. John
et al., 1995) and corresponds with a robust microglia and astrocyte
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response (Bartel, 2012; Bartel and Finger, 2013; Riquier and Sollars,
2017). The developmental difference in the microglia response may be
due to the higher baseline inflammatory profile and phagocytic nature
(Crain et al., 2013; Hammond et al., 2019; Li et al., 2019) and quantity
(Nikodemova et al., 2015; Riquier and Sollars, 2017) of microglia in the
early postnatal brain. Microglia genotype and inflammatory profile can
in turn drive astrocyte reactivity and function, both promoting (Bylicky
et al., 2018; Shinozaki et al., 2017) and inhibiting (Liddelow et al., 2017)
injury recovery. However, the astrocyte response to neonatal CTX has yet
to be assessed.
Microglia viability is dependent on the receptor tyrosine kinase
colony-stimulating factor 1 receptor (CSF1R; Elmore et al., 2014). When
integrated into rodent food, CSF1R inhibitors such as PLX3397 and
PLX5622 (Plexxikon Inc.) results in> 97% depletion of microglia in mice
while maintaining animal health and peripheral monocyte/macrophage
quantities (e.g. Elmore et al., 2018; Elmore et al., 2015; Elmore et al.,
2014; Hilla et al., 2017; Waisman et al., 2015). Such methods of micro-
glia depletion have been used in several mouse models such as hippo-
campal neural loss (Rice et al., 2015), optic nerve injury (Hilla et al.,
2017), sciatic nerve ligation (Lee et al., 2018), postoperative cognitive
decline (Feng et al., 2017) and numerous neurological disorders
(Reviewed in Han et al., 2018). However, consumption-based PLX3397
and PLX5622 administration does not provide comparable microglia
depletion in rats. Use of food-based drug delivery severely limits the drug
application in preweaning animals. While PLX5622-integrated chow
consumed by a mouse dam depletes microglia in embryonic and pre-
weaning animals, this indirect administration results in reduced litter
size, increased early postnatal mortality and health deficits in surviving
pups (Rosin et al., 2018). In the current study, we developed a novel
protocol of intraperitoneal administration PLX5622 to deplete microglia
in both the early postnatal and adult rat brain. We subsequently quan-
tified the microglia and astrocyte presence in the rNTS during normal
development and following neonatal or adult CTX, using PLX5622 to
determine the necessity of microglia for astrogliosis in the CTX paradigm.
2. Materials and methods
2.1. Subjects
Male and female Sprague Dawley rats (n¼ 72) bred in the University
of Nebraska at Omaha Vivarium were used, with date of birth being
denoted as P0 (postnatal day 0). A rat model was selected to correspond
with our previous work demonstrating differences in recovery and
microglia responses between CTX occurring in adult or neonatal rats
(Martin et al., 2019; Riquier and Sollars, 2017; Sollars, 2005). Every
condition included both male and female rats randomly assigned from at
least two litters. Rats were kept on a 12:12 light-dark cycle in clear
Plexiglas cages with free access to tap water and food pellets (Teklad).
Rats were weaned at P25 and socially housed. All procedures were car-
ried out in accordance with the National Institutes of Health guide for the
care and use of Laboratory animals (NIH Publications No. 8023, revised
1978) and were approved by the local Institutional Animal Care and Use
Committee.
2.2. Chorda tympani transection
Rats underwent chorda tympani transection at either P10 (n¼ 31) or
P50 (n¼ 27) as previously described (Martin et al., 2019; Riquier and
Sollars, 2017; Sollars, 2005). Briefly, after anesthetization with metho-
hexital sodium (60mg/kg i.p.), the right CT was accessed through an
incision in the ventromedial neck, crushed, and the CT was evulsed.
Animals were then placed on a heating pad until recovery. The left CT
remained intact to serve as an internal sham surgery control. While using
the sham side as a control is common following CTX (e.g. Bartel and
Finger, 2013; Riquier and Sollars, 2017; Sollars, 2005), there is some
evidence of contralateral alternations to electrophysiological nerve
activity (Martin and Sollars, 2015; Wall and McCluskey, 2008) and taste
bud volume (Guagliardo and Hill, 2007; Li et al., 2015). To validate the
sham side as a control, sham-side microglia and astrocyte densities were
compared to age-matched intact, non-surgical animals.
2.3. Microglia inhibition via intraperitoneal injection of PLX5622
Prior CSF1R inhibitor studies using PLX3397/5622-integrated chow
treated animals for at least 1 week prior to their experimental manipu-
lation (e.g. Elmore et al., 2014; Okunukia et al., 2019). To ensure
adequate microglia depletion for neonatal surgeries, we began our
treatments at P1, with an equivalent pre-surgery treatment duration (9
days) for adults. Pilot testing indicated that while a single daily injection
of 0.65% PLX5622 suspended in 5% dimethyl sulfoxide and 20% Kolli-
phor RH40 in 0.01M PBS was sufficient for neonatal microglia depletion,
adult depletion required injections twice daily (10–12 h apart). Starting
at P1 (for P10 CTX) or P41 (for P50 CTX), additional rats were injected
with either PLX5622 (50mg/kg; n¼ 4–5/condition) or a vehicle solution
(n¼ 3–4/condition) once (neonates) or twice (adult) a day until being
sacrificed 4 days after surgery.
2.4. Perfusion and tissue extraction
Following anesthesia with a mixture of ketamine/xylazine at 4 days
post-CTX, rats were transcardially perfused with a modified Krebs solu-
tion (pH 7.3) followed by 4% paraformaldehyde. Brains were extracted
and post-fixed overnight in 4% paraformaldehyde at 4 C. Brainstems
were sectioned horizontally at 40 μm on a vibrating microtome, consis-
tent with previous work (Martin et al., 2019; Riquier and Sollars, 2017).
2.5. Immunohistochemistry
Alternating free-floating sections were stained for either microglia or
astrocytes with antibodies against Iba1 or GFAP, respectively. To test for
microglia phagocytic capacity, separate brains were processed using an
antibody against CD68. For all antibodies, 0.01M PBS (pH 7.4) was used
for all solutions and rinses unless otherwise specified. For each immu-
nohistochemistry (IHC) run, between 6 and 8 brains of mixed conditions
were processed simultaneously to mitigate any potential influence of
inter-run chromogen variability. Spleen tissue was used as a positive
control for CD68 due to the high quantity of resident CD68 þ cells (Olsson
et al., 2012; company data sheet). Brain (Iba1 and GFAP) and spleen
(CD68) sections were processed with the primary antibodies omitted as
negative controls. No staining was observed on any negative control
sections (see Fig. 1 for photomicrographs of control spleen sections).
2.6. Primary antibodies
Ionized calcium-binding adapter molecule 1 (Iba1). A common
microglia marker (Bartel, 2012; Bartel and Finger, 2013; Riquier and
Sollars, 2017), Iba1 expression is specific to microglia/macrophages
Fig. 1. Control spleen sections for immunohistochemistry controls with (A) the
full protocol and (B) omitting the primary antibody. While no CD68 was
observed in negative control sections, all positive control sections displayed
robust CD68 staining.
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(Imai et al., 1996; Ito et al., 1998). After rinsing 3 times for 10min each,
sections were blocked against endogenous peroxidase for 30min in 0.3%
H2O2 in methanol, followed by another rinse cycle. Tissue was blocked
against non-specific binding in 2% normal goat serum (NGS), 1% BSA,
and 0.3% Triton X-100 for 1 h at room temperature, then incubated with
a rabbit anti-Iba1 antibody (1:10,000, Wako, Cat # 019–19741, RRID:
AB_839504) in the blocking solution for 36–48 h at 4 Celsius.
Cluster of differentiation 68 (CD68). CD68 is a scavenger receptor
commonly expressed on monocytic cells that facilitates clearage of
cellular debris via phagocytosis (Suzuki et al., 2014; Zabel et al., 2016)
and can be upregulated on microglia following injury (e.g. Goranova
et al., 2015; Graeber et al., 1998). Sections were rinsed twice for 5-min
each in tris buffered saline (TBS; pH 7.6) containing 0.025% Triton
100-X, followed by blocking for 2 h in TBS containing 10% NGS and 1%
BSA at room temperature. Overnight incubation at 4 Celsius with a
rabbit anti-CD68 antibody (1:500 in 1% BSA in TBS, Abcam, Cat #
ab125212, RRID: AB_10975465) followed. Tissue was then rinsed and
placed in the 0.3% H2O2 in methanol for 30min.
Glial fibrillary acid protein (GFAP). Part of an intermediate filament
protein family, GFAP is upregulated following injury and is necessary for
astrogliosis (Reviewed in Sofroniew and Vinters, 2010). Thus, any as-
trocytes that are reacting to CTX will be detectable with an antibody
against GFAP. Sections were rinsed 5 times for 5min each in PBS con-
taining 0.2% Triton 100-X, were blocked for 90min in 5% NGS, then
incubated in a rabbit anti-GFAP antibody (1:13,000, Abcam, Cat #
ab7260, RRID: AB_305808) solution containing 5% NGS overnight 4
Celsius. Sections were then rinsed and blocked in 0.3% H2O2 in meth-
anol for 30min.
2.7. Secondary antibody and visualization
All sections were rinsed 3 times for 10min each in PBS, then incu-
bated with a goat-anti-rabbit antibody (Vector Laboratories, Cat # BA-
1000, RRID: AB_2313606, 1:1000 in 2% NGS, 0.3% Triton X-100) for
2 h at room temperature. Following a rinse cycle, sections were placed in
the 2% avidin-biotin complex solution containing 0.1% Triton X-100
(Vector Laboratories, Burlingame, CA) for 1 h, rinsed, then placed in a
diaminobenzidine solution (0.05% with 0.125% nickel ammonium sul-
fate and 0.01% H2O2). The nickel was omitted from GFAP sections,
which were counterstained with 1% cresyl violet.
2.8. NTS identification
All visualization and quantification was performed with a brightfield
microscope, with the NTS being visualized using phase-contrast (Martin
et al., 2019). The most prominent landmarks of the NTS are located on
approximately 4 sections (160 μm) halfway through its dorsal-ventral
extent, which consist of the solitary tract being visible in the medial
NTS across the rostral/caudal plane and prominent facial nuclei rostral to
the NTS. Data was collected from these 4 sections, as well as 160 μm
dorsally and ventrally, for a total of 12 sections (480 μm), as we have
done previously (Riquier and Sollars, 2017). Because the CT terminal
field occupies the rostral most 1/3 of the NTS (Corson and Hill, 2011), this
area was identified and traced using a 250 μm 250 μm square grid
projected onto the tissue using the software Neurolucida software (MBF
Bioscience, https://www.mbfbioscience.com, RRID:SCR_001775) as we
have done previously (Riquier and Sollars, 2017).
2.9. Cell quantification and correction
All cells were visualized using a 20 (1.6) objective lens and were
quantified by placing Neurolucida overlay markers on each cell body
(microglia and CD68) or cresyl violet stained GFAP þ cell (astrocytes).
Cells were counted by trained, blind researchers on alternating sections
for each cell type and were only counted if the soma was entirely within
the outlined rNTS. Markers were totaled using the companion software
NeuroExplorer. To mitigate any potential overcounting, an Abercrombie
correction (Abercrombie, 1946) was performed using the following for-
mula: Corrected Counts ¼ Raw Counts * (section thickness/[section
thickness þ cell height]). Cell heights were determined by carefully
measuring the soma diameter of a random sampling (~5%) of microglia
and astrocytes from control animals of each age, generating a single mean
value each for microglia and astrocyte height.
2.10. Data analysis
All analyses were conducted using SPSS Statistics 24 (IBM). Density of
cells in the rNTS were used for all analyses to facilitate comparisons
across age conditions and varying rNTS sizes. The volume of each rNTS
side (right or left) for each animal was calculated by summing the total
traced area on each side and multiplying those values by the section
thickness (40 μm). Raw cell counts for each antibody were summed to
obtain a single value for each rNTS side per animal. These totals were
then divided by the respective rNTS volumes and multiplied by 200,000
to get the density of cells (number of cells/200,000 μm3).
The efficacy of PLX5622-driven microglia depletion was determined
using independent samples t-tests comparing sham sides of PLX5622
treated animals to the sham sides of Vehicle treated animals. Due to
previous PLX5622 administration during development resulting in
abnormal weight gain in mouse pups (Rosin et al., 2018), weights were
compared between PLX5622 and vehicle-treated neonatal rats for each
day of treatment using independent samples t-tests. These weights were
also used to ensure pup health.
The effect of CTX onmicroglia and astrocyte densities in the rNTS was
determined using a 2 (Surgical Side [Sham vs. CTX]) X 2 (Surgical Age
[P10 vs P50]) repeated measures ANOVA. Post-hoc analyses were per-
formed using paired-samples t-tests comparing sham sides to CTX sides
within each surgical age. To test for contralateral effects of CTX on
microglia and astrocyte densities, independent samples t-tests were used
to compare the sham side of surgical animals to densities from age-
matched intact, non-surgical animals. For ANOVAs, Mauchly's Test of
Sphericity was performed to ensure the sphericity assumption was not
violated.
Microglia density is highest in the developing rNTS (Riquier and
Sollars, 2017), whereas astrocyte quantity increases in other brainstem
regions during the first 3 weeks of life (Bandeira et al., 2009). Therefore,
direct comparisons of raw condition means across age may mask certain
effects. To account for this, the percent increase from baseline cell den-
sity between transected and sham sides for each animal was calculated
using the formula: [{(transected side density/intact side density) * 100}
 100]. Independent samples t-tests were used to compare the percent of
change in microglia and astrocyte density between surgical ages within
each days-post condition.
3. Results
3.1. I.P. Injection of PLX5622 severely depletes microglia in developing
and adult rats without impacting astrocyte densities
Animals were treated with PLX5622 or vehicle starting nine days
prior to surgery (P1 or P41). To assess the timing of microglia depletion,
two adult and two neonatal rats were sacrificed after 3 days of PLX5622
administration, and we observed 80% and 90% ( 4%) microglia
depletion in the brainstem, respectively. Two additional adult and
neonatal rats were sacrificed after 7 days of treatment, and microglia loss
had increased to 93% ( 1%) for both ages. The remaining brains were
collected 4 days after surgery, for a total of 14 days of treatment. The
weights of rat pups did not differ between PLX5622 and vehicle treated
neonates (ps> .1; Fig. 2) and were consistent with previous reports on rat
pup weights (Bandeira et al., 2009) indicating that drug treatment did
not impact normal pup health or growth.
Microglia densities did not differ on the intact sides of vehicle and
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untreated animals at P14 t (7)¼ 0.265, p¼ .768, or P54 t (8)¼0.973,
p¼ .359, indicating that the vehicle had no impact on microglia density.
Relative to vehicle-treated animals, 14 days of i.p. PLX5622 injections
reduced microglia density in both neonates (96% loss; t (6)¼23.576,
p< .001, d¼ 16.67) and adults (99% loss; t (6)¼10.567, p< .001,
d¼ 7.47; Fig. 2). This loss is comparable or greater than that of admin-
istration via food (Elmore et al., 2018; Hilla et al., 2017), and oral gavage
(Lee et al., 2018).
Relative to P54 untreated animals, neither the PLX t (7)¼ 1.527,
p¼ .171 nor Vehicle treatments t (5)¼ 2.157, p¼ .08, d¼ 0.34 influ-
enced astrocyte density on the intact side. This held true for P14 animals
treated with PLX t (6)¼ 0.466, p¼ .658 or Vehicle t (6)¼ 0.476, p¼ .651
relative to untreated animals. Therefore, regardless of age, neither
vehicle treatments nor microglia depletion using PLX5622 impacted
baseline astrocyte density, in contrast to other i.p. microglia depletion
methods such as liposome-encapsulated clodronate intraperitoneal
microglia depletion (Han et al., 2019).
3.2. There is a larger microglia response to adult CTX
Because astrocyte and microglia densities on both the intact and
transected sides did not differ between untreated and vehicle-treated
animals (ps > .1), these values were combined for analyses. Four days
after CTX there was a significant main effect of surgery on microglia
density F (1, 17)¼ 195.004, p< .001. The main effect of age was also
significant F (1, 17)¼ 4.549, p¼ .048, as was the interaction between
surgery and age F (1, 17)¼ 6.345, p¼ .022, suggesting that the effect of
surgery differed across surgical age. T-tests revealed that consistent with
previous work (Nikodemova et al., 2015; Riquier and Sollars, 2017)
baseline microglia densities were highest during early development t
(19)¼ 4.978, p< .001, d¼ 2.13. Microglia density increased on the
transected side after both P10 t (8)¼ 8.632, p< .001, d¼ 3.42 and P50 t
(9)¼ 11.183, p< .001, d¼ 3.37 CTX (Fig. 3A–E). While the percent in-
crease from control levels was larger after P50 CTX t (17)¼ 4.075,
p¼ .001, d¼ 1.89 (Fig. 3F), microglia density on the transected side did
not differ between P10 and P50 CTX t (17)¼ 0.630, p¼ .537. No CD68
was detected at either surgical age.
3.3. The neonatal astrocyte response is larger than adults’
Consistent with previous work (Taft et al., 2005), astrocytes did not
differ overall across age F (1, 13)¼ 1.619, p¼ .225. However, there was a
significant main effect of surgery on astrocyte density F (1, 13)¼ 50.643,
p< .001 and the interaction between surgery and age was significant F
(1, 13)¼ 20.339, p¼ .001, indicating that the astrocyte increase
following CTX differed across age. Indeed, t-tests revealed that although
astrocytes increased on the transected side at both P10 t (7)¼ 6.491,
p< .001, d¼ 2.12 and P50 t (6)¼ 4.443, p¼ .004, d¼ 1.73 (Fig. 3G–K),
the percent increase was significantly larger at P10 t (13)¼ 3.322,
p¼ .006, d¼ 1.78 (Fig. 3L).
3.4. Microglia are required for the astrocyte response to CTX in adults but
not neonates
Similar to untreated animals, P10 CTX induced a significant increase
in astrocyte density on the transected side of PLX5622-treated animals t
(3)¼ 6.282, p¼ .008, d¼ 4.01. The magnitude of the increase was not
affected by PLX5622 treatment t (10)¼ 1.292, p¼ .225, suggesting the
astrocyte response to P10 CTX is not dependent on microglia. However,
microglia depletion using PLX5622 abolished the astrocyte response to
Fig. 2. Compared to vehicle-treated animals (A), intraperitoneal injection of PLX5622 (B) depletes microglia in the neonatal and adult rat NTS (C). (D) Weights of
PLX5622 and vehicle treated pups did not differ. Scale bar is 100 μm. Lines (C) and bars (D) denote means  SEM.*p< .001.
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P50 CTX t (4)¼ 1.699, p¼ .165, d¼ 0.70 (Fig. 3M). This indicates that
microglia are required for the astrocyte response to P50 CTX.
4. Discussion
In the current study, we provide evidence of developmental differ-
ences in both the magnitude andmicroglia-dependency of NTS astrocytes
following CTX. We also demonstrate that i.p. injection of the colony-
stimulating factor receptor 1 antagonist PLX5622 ablates microglia
from the developing and adult rat brain yet has no impact on baseline
astrocyte quantities. While CTX induced an increase in both glia types in
the rNTS, the nature of the response differed developmentally. While the
microglia response to adult CTX was larger than that of neonates, the
astrocyte response was largest in neonates. Further, microglia depletion
eliminated the astrocyte response to adult CTX, yet the neonatal astrocyte
response was unaffected.
4.1. Developmental difference in the glia response in the injured rNTS
Consistent with our previous work, microglia density increased in the
rNTS following ipsilateral CTX, independent of surgical age, although a
much greater increase was observed in adults (Riquier and Sollars, 2017).
The larger adult response is likely driven by the higher baseline microglia
density observed neonatally. Further, as the microglia densities on the
surgical side of both age conditions were equivalent, it is possible that
there is a ceiling effect on rNTS microglia density. The increase in
microglia density is likely due primarily to local proliferation with
limited migration as is seen following adult mouse CTX (Bartel, 2012)
and whole facial nerve axotomy (Tay et al., 2017). We further observed
an increase in astrocytes in the ipsilateral rNTS four days following both
adult and neonatal rat CTX, consistent with observations in the adult
mouse (Bartel, 2012; Bartel and Finger, 2013). However, while the
astrocyte response to adult rat CTX was a modest 13% increase, the in-
crease in the neonatal brain was a substantially larger 64%. This increase
was not due to differences in baseline astrocyte values. An increase in
astrocyte quantity is commonly preceded by a microglia response which
can trigger pathway-dependent differences in reactive astrocyte function
(Liddelow et al., 2017; Shinozaki et al., 2017).
It is possible that the increased astrocyte response observed following
neonatal CTX is due to the degree of CT fiber loss post-CTX. Neonatal CTX
results in substantial CT fiber loss in the NTS 50 days later (Martin et al.,
2019), while adult CTX has minimal fiber loss (Reddaway et al., 2012).
Although the onset of CT fiber degeneration in neonatal rats has not been
established, in adult hamsters, limited CT fiber degeneration begins 2
days after CTX (Whitehead et al., 1995), corresponding with loss of
innervated taste buds on the tongue (Sollars, 2005). Unlike in the
degenerating facial motor nucleus after facial nerve axotomy (Graeber
et al., 1998), rNTS microglia in the CTX paradigm do not express CD68
4-days post CTX, indicating a lack of phagocytic capacity. However
neonatal CTX-induced taste bud loss is not observed until a week after
CTX (Sollars, 2005), suggesting that CT denervation may be delayed.
Future research is therefore needed to see if microglia acquire the ability
to phagocytose at a later point. It is also possible that phagocytosis of
degenerating CT fibers is performed by astrocytes, as in the CTX para-
digm more astrocytes corresponds to greater CT fiber loss (Martin et al.,
2019). Damaged fibers can release ATP which can induce astrocyte
reactivity (Burda et al., 2016). Indeed, the lack of CD68 þmicroglia
following CTX at either developmental stage suggests that perhaps as-
trocytes, which phagocytose via ATP-binding cassette transporter A1
(Morizawa et al., 2018), are responsible for phagocytosing debris
following CTX, although this hypothesis necessitates further study.
4.2. Developmental difference in necessity of microglia for induction of
astrocyte response
We observed that preventing the substantial microglia response to
adult CTX consequently prevented an astrocyte increase. Comparable
microglia depletion occurring in neonatal rats had no impact on the
astrocyte response to CTX, suggesting developmental differences in the
mechanisms of CTX-induced astrogliosis. While we cannot eliminate the
possibility that the remaining 4% of microglia in the neonatal brain were
sufficient to induce an astrocyte response of comparable magnitude and
Fig. 3. Microglia (A–F) and astrocytes (G–L) in the intact (A, C, G, I) and transected (B, D, H, J) rNTS 4 days after CTX. While both cell types increase in quantity
regardless of surgical age (E, K), surgery at postnatal day 10 induced a smaller microglia (F) and a larger astrocyte (L) response than surgery at postnatal day 50.
Microglia depletion with PLX5622 has no effect on the neonatal astrocyte response to CTX but eliminates the adult astrocyte response (M). Each point represents data
from a single animal. Connecting lines (E, K, M) show paired comparisons within a single animal. Error bars denote means  SEM. *p< .05. Scale bar is 50 μm.
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timeliness as microglia-replete animals, this possibility seems unlikely.
The modest microglia increase following neonatal CTX occurs concur-
rently with a substantial astrocyte response, suggesting an independent,
or at least additive, means of astrocyte activation.
While astrocytes can promote injury recovery (Pekny and Pekna,
2014), inflammatory cytokines such as tumor necrosis factor α can
induce A1 astrocyte activation, which are deleterious to recovery (Lid-
delow et al., 2017). The milieu of the developing brain is inherently more
inflammatory than that of the adult brain (Crain et al., 2013) which,
coupled with the larger neonatal astrocyte response may contribute to
the lack of recovery observed following neonatal CTX. However, since
microglia are canonically a primary source of neuroinflammation in the
developing brain, their absence via PLX5622 treatment likely attenuates
the baseline inflammatory profile of the brain. Further research is needed
to test the possibility that while the post-CTX astrocyte quantities are
comparable between PLX5622 treated and control animals, reduced
neuroinflammation may alter astrocyte function.
We observed neither increased mortality nor abnormal weight
changes when starting PLX5622 treatments at postnatal day 1 in rats. A
recent study provided PLX5622 in food to pregnant mouse dams as a
method of depleting microglia in the fetuses. The dams’ consumption of
the food started at post-conception day 3.5 (E3.5) and resulted in suc-
cessful depletion of microglia by> 99% in the fetal mice by E15.5.
Despite treatment cessation causing postnatal microglia repletion,
depletion during this prenatal period resulted in decreased litter size, as
well as increased apoptotic cells, decreased neurons, and abnormal
weight gain relative to controls by postnatal day 5 (Rosin et al., 2018).
The timing of PLX5622 administration is likely a substantial reason for
the differences in pup viability we found. Microglia migrate into the CNS
at E10.5 in mice (Ginhoux et al., 2010). Microglia depletion during this
period appears to disrupt critical stages of embryonic neural develop-
ment, yet postnatal development demonstrates resiliency to microglia
loss.
5. Conclusions
In summary, we demonstrated glial responses to CTX that varied
based on developmental stage. Adult CTX induces large microglia and
small astrocyte responses, but CTX at P10 results in small microglia and
large astrocyte responses, which are associated with differences in CTX
recovery (Kopka et al., 2000; Martin et al., 2019; Reddaway et al., 2012;
Sollars, 2005; St. John et al., 1995). We are the first to demonstrate that
i.p. administration of PLX5622 to both early postnatal and adult rats
depletes microglia without impacting animal health (as assessed by
weight) or astrocyte quantity. While such depletion eliminated the adult
astrocyte response, the neonatal response appeared unaffected, showing
that microglia are likely not required for neonatal CTX-induced astro-
gliosis. Our findings suggest the presence of pathway-specific develop-
mental differences which may contribute to differences in recovery
across development. Our results add to existing knowledge regarding
differences in glia function across development and factors that may
contribute to why the developing gustatory system has difficulty recov-
ering from injury. Our findings highlight the potential importance of
central glia to both the developing and injured gustatory system and
suggest differences in reciprocal interactions between microglia and as-
trocytes across maturational stages.
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